MET expression based on
|
Comparison | Statistical significance |
Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
<1E-12 |
Normal-vs-Stage2 |
1.58869999999922E-06 |
Normal-vs-Stage3 |
<1E-12 |
Normal-vs-Stage4 |
1.62447832963153E-12 |
Stage1-vs-Stage2 |
1.263630E-03 |
Stage1-vs-Stage3 |
8.703400E-01 |
Stage1-vs-Stage4 |
6.924300E-02 |
Stage2-vs-Stage3 |
8.006300E-04 |
Stage2-vs-Stage4 |
4.51879999996407E-06 |
Stage3-vs-Stage4 |
4.003600E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62458935193399E-12 |
Normal-vs-AfricanAmerican |
1.161999999999E-06 |
Normal-vs-Asian |
5.92847992919587E-12 |
Caucasian-vs-AfricanAmerican |
7.577600E-01 |
Caucasian-vs-Asian |
4.474200E-01 |
AfricanAmerican-vs-Asian |
8.322200E-01 |
|
|
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
<1E-12 |
Normal-vs-Female |
<1E-12 |
Male-vs-Female |
2.172200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
<1E-12 |
Normal-vs-Age(41-60Yrs) |
<1E-12 |
Normal-vs-Age(61-80Yrs) |
<1E-12 |
Normal-vs-Age(81-100Yrs) |
3.681700E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.091810E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.630100E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.310400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.759800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.812200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.553000E-01 |
|
|
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Classical-VS-Tall |
5.824300E-02 |
Classical-VS-Follicular |
<1E-12 |
Classical-VS-Other |
9.519500E-02 |
Classical-VS-Normal |
<1E-12 |
Tall-VS-Follicular |
1.45639056370328E-12 |
Tall-VS-Other |
3.838600E-03 |
Tall-VS-Normal |
1.64124269730337E-12 |
Follicular-VS-Other |
2.140500E-02 |
Follicular-VS-Normal |
4.21069999978485E-07 |
Other-VS-Normal |
1.496330E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
<1E-12 |
Normal-vs-N1 |
1.58761892521397E-14 |
N0-vs-N1 |
9.77359999999594E-05 |
|
|